CN106222201B - 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 - Google Patents
一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 Download PDFInfo
- Publication number
- CN106222201B CN106222201B CN201610744414.4A CN201610744414A CN106222201B CN 106222201 B CN106222201 B CN 106222201B CN 201610744414 A CN201610744414 A CN 201610744414A CN 106222201 B CN106222201 B CN 106222201B
- Authority
- CN
- China
- Prior art keywords
- cells
- car
- cord blood
- cell
- positive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | 给药细胞 | 给药体积(μL) | 给药量(个/只) |
空白组 | 无(PBS) | 200 | 0 |
阴性对照组 | 脐带血T细胞 | 200 | 1×106 |
实验I组 | 脐带血CAR-T细胞 | 200 | 1×106 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610744414.4A CN106222201B (zh) | 2016-08-27 | 2016-08-27 | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610744414.4A CN106222201B (zh) | 2016-08-27 | 2016-08-27 | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106222201A CN106222201A (zh) | 2016-12-14 |
CN106222201B true CN106222201B (zh) | 2017-11-28 |
Family
ID=57555018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610744414.4A Active CN106222201B (zh) | 2016-08-27 | 2016-08-27 | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106222201B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108239623B (zh) * | 2016-12-23 | 2020-03-24 | 上海恒润达生生物科技有限公司 | 一种混合cart细胞的制备方法和应用 |
CN108728415A (zh) * | 2017-04-17 | 2018-11-02 | 沈阳美达博生物科技有限公司 | 一种利用cd3制备car-t细胞的方法 |
CN107523550A (zh) * | 2017-08-08 | 2017-12-29 | 安徽惠恩生物科技股份有限公司 | 一种针对小细胞肺癌的Car‑T细胞制备方法 |
CN109385402A (zh) * | 2017-08-11 | 2019-02-26 | 上海恒润达生生物科技有限公司 | 一种等比例混合两种靶点cart细胞的制备方法及应用 |
CN107904259A (zh) * | 2017-11-01 | 2018-04-13 | 上海隆耀生物科技有限公司 | 一种治疗艾滋病合并淋巴瘤的car‑t细胞及其制备方法和应用 |
CN108315298B (zh) * | 2018-02-07 | 2020-10-20 | 安徽古一生物科技有限公司 | 一种γδT细胞的培养方法 |
CN108660113A (zh) * | 2018-05-21 | 2018-10-16 | 杭州启澜生物医学技术有限公司 | 一种制备改良型car-t细胞的方法 |
CN108949825A (zh) * | 2018-07-30 | 2018-12-07 | 苏州茂行生物科技有限公司 | 一种靶向her2的car-t细胞的制备方法及应用 |
CN109337930B (zh) * | 2018-09-30 | 2020-10-30 | 北京鼎成肽源生物技术有限公司 | 一种afft1细胞 |
CN110157683A (zh) * | 2019-05-29 | 2019-08-23 | 南京艾德免疫治疗研究院有限公司 | 一种治疗白血病的car-t细胞制剂的制备方法 |
CN111154720B (zh) * | 2020-01-14 | 2020-12-25 | 南京鼓楼医院 | 一种car-t培养基及其应用 |
CN112375740A (zh) * | 2020-11-16 | 2021-02-19 | 苏州米苏生物技术有限公司 | Car-t细胞培养基及其应用 |
CN117925535A (zh) * | 2024-02-01 | 2024-04-26 | 南方医科大学珠江医院 | 一种car-t细胞的培养方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105408473A (zh) * | 2013-05-14 | 2016-03-16 | 得克萨斯州大学系统董事会 | 工程化嵌合抗原受体(car)t细胞的人应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012050374A2 (en) * | 2010-10-13 | 2012-04-19 | Innocell, Inc. | Immunotherapy for solid tumors |
WO2013074916A1 (en) * | 2011-11-18 | 2013-05-23 | Board Of Regents, The University Of Texas System | Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
EP3828265A1 (en) * | 2014-06-06 | 2021-06-02 | Bluebird Bio, Inc. | Improved t cell compositions |
US20160228547A1 (en) * | 2015-02-06 | 2016-08-11 | Batu Biologics, Inc. | Chimeric antigen receptor targeting of tumor endothelium |
US20160237407A1 (en) * | 2015-02-17 | 2016-08-18 | Batu Biologics, Inc. | Universal donor chimeric antigen receptor cells |
-
2016
- 2016-08-27 CN CN201610744414.4A patent/CN106222201B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105408473A (zh) * | 2013-05-14 | 2016-03-16 | 得克萨斯州大学系统董事会 | 工程化嵌合抗原受体(car)t细胞的人应用 |
Non-Patent Citations (1)
Title |
---|
14-Initial Comparisons of Three Apheresis Platforms for Supporting the Collection of CD3+ Cell for CAR-T Production;D.Watson等;《Cytotherapy》;20160601;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN106222201A (zh) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106222201B (zh) | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 | |
CN104204194B (zh) | 生产自然杀伤细胞的方法、由该方法生产的自然杀伤细胞以及包含该自然杀伤细胞的用于治疗癌症和感染性疾病的组合物 | |
CN102268405B (zh) | 自体nk细胞体外活化扩增培养的方法及其专用培养基 | |
CN104357391B (zh) | 同时诱导扩增Vα24+iNKT细胞和CD3‑CD56+NK细胞的方法 | |
KR101419711B1 (ko) | 항원제시세포의 활성화 처리방법 | |
CN103756963A (zh) | 一种体外扩增nk细胞的方法 | |
US11834677B2 (en) | Expansion and use of expanded NK cell fractions | |
CN104789527B (zh) | 一种自体自然杀伤细胞鸡尾酒式培养的制备方法及其试剂盒产品 | |
CN106544365B (zh) | 一种人抗cd19嵌合抗原受体修饰的cik的制备方法及应用 | |
CN108220239A (zh) | 一种刺激诱导单个核细胞扩增为γδT细胞的组合物及其应用 | |
CN107119013A (zh) | 一种增强型cik细胞的制备方法及白术多糖和枸杞多糖的应用 | |
CN108949685A (zh) | 一种体外诱导扩增高杀伤活性γδT细胞的方法 | |
Peng et al. | Tumor‐associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma | |
CN107043749B (zh) | 一种肿瘤浸润t淋巴细胞的分离诱导方法 | |
Sudarsanam et al. | Influence of culture conditions on ex vivo expansion of T lymphocytes and their function for therapy: Current insights and open questions | |
KR20230008691A (ko) | 면역세포의 생체외 배양, 유도, 활성화, 동결보존 방법 및 그 세포 은행의 구축 | |
CN107502590A (zh) | 一种人类脐带血造血干细胞高效扩增nk细胞的方法 | |
CN106554942A (zh) | 一种高效的临床级cd56+群免疫细胞的制备方法 | |
CN109825473A (zh) | 一种采用tlr7激动剂刺激的自体外周血淋巴细胞的培养方法 | |
CN104894072B (zh) | 一种自体自然杀伤细胞增殖的制备方法及其应用 | |
CN106754704B (zh) | 免疫细胞体外诱导扩增的方法 | |
CN104232582A (zh) | 泊洛沙姆在诱导造血干祖细胞增殖和/或巨核分化中的用途 | |
CN105779390A (zh) | 一种免疫增强型capri细胞制备方法 | |
CN109957543A (zh) | 利用脐带血大量扩增脐血nk细胞的方法 | |
CN107904259A (zh) | 一种治疗艾滋病合并淋巴瘤的car‑t细胞及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 316, floor 3, building 1, block B, No. 80, xingshikou Road, Haidian District, Beijing 100093 Patentee after: Beijing Yimiao Shenzhou Pharmaceutical Technology Co., Ltd Address before: 100000 , Tsinghua Park, Tsinghua University, research and research building, eight floor, B, Beijing Patentee before: BEIJING IMMUNO SHENZHOU MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161214 Assignee: Shanghai xianbo Biotechnology Co., Ltd Assignor: Beijing Yimiao Shenzhou Pharmaceutical Technology Co.,Ltd. Contract record no.: X2020320000048 Denomination of invention: A method for preparing car-t cells, the prepared car-t cells and their application Granted publication date: 20171128 License type: Exclusive License Record date: 20200722 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Shanghai xianbo Biotechnology Co., Ltd Assignor: Beijing Yimiao Shenzhou Pharmaceutical Technology Co.,Ltd. Contract record no.: X2020320000048 Date of cancellation: 20211218 |
|
EC01 | Cancellation of recordation of patent licensing contract |